Editorial / Standards
How we prepare content.
Our content is intended for understanding, not selling. That is why sources are listed, limitations are clearly stated, and claims are separated from opinions.
Last updated: 3 November 2026
Purpose of content
The content on RuskiPeptidi.com is informational. Its goal is to explain what peptides are, what research shows and where the limitations are. It does not replace medical advice, pharmaceutical judgement or a legal opinion.
We explicitly separate:
- mechanism — what happens at the level of cells or receptors;
- preclinical result — what was observed in animals or cultures;
- clinical evidence — what was confirmed in humans in controlled studies;
- regulatory status — what is approved and where.
Sources and hierarchy of evidence
We prioritise primary sources: peer-reviewed scientific articles, regulatory documents (EMA, FDA and national agencies), official guidelines and technical documentation. Secondary sources, such as review articles and professional journals, are used for context.
For every study we ask:
- whether it was peer-reviewed and who funded it;
- whether it involved cells, animals or humans;
- what the sample size was and whether the control was adequate;
- whether the results were independently replicated;
- whether the conclusion we cite follows from the data or from the authors’ interpretation.
If a source does not support a claim, we do not publish the claim. If the evidence is weak, we say so.
Review and corrections
Every article is reviewed by an editor before publication. We check structure, references, grammar and compliance with our rules on medical claims. The publication date and the last update date are visible on the page.
If you find an error, write to us at info@ruskipeptidi.com. Substantiated corrections are published and, where necessary, the source is supplemented. If it is a substantive change, we mark it in the article.
Independence
Content is not sponsored. The site does not sell products and does not receive payment for publication. Links to the catalog are internal. If we introduce affiliate links in the future, we will clearly mark them on the page.
Conclusions are shaped by evidence, not by potential commercial interests. If a peptide has no clinical evidence, we say so regardless of how attractive the topic is.
Authors and reviewers
Content is currently published under the collective name RuskiPeptidi Editorial Team. We do not name authors and reviewers until they are confirmed and until the person has given written consent. Invented biographies, qualifications or reviews are expressly prohibited.
When a reviewer or author is appointed, we will list their name, qualifications, area of review and any public profiles here. Until then, content remains editorial.
Image origin
The current illustrations were generated with the FLUX.2 [klein] 4B model and are symbolic. They do not show actual product packaging. This is indicated in the footer, on product pages and below article illustrations.
When real photographs become available, they will replace the illustrations under the same file names and will be accompanied by author, licence and date. The AI disclosure will then be removed automatically via the setting in src/data/image-sources.ts.
Use of AI tools
When preparing content, we may use tools for language and structural editing. The final content is reviewed by an editor responsible for accuracy, context and citation. We do not use AI tools as a data source and do not publish texts without human review.
Editorial contact
RuskiPeptidi Editorial Team · info@ruskipeptidi.com
For citation: RuskiPeptidi Editorial Team. (2026). Editorial policy. RuskiPeptidi.com. https://ruskipeptidi.com/editorial/